Assessment of toxic effects and survival in treatment deescalation with radiotherapy vs transoral surgery for HPV-associated oropharyngeal squamous cell carcinoma …

…, JE Jackson, M Dzienis, J O'Neil, S Chandarana… - JAMA …, 2022 - jamanetwork.com
Importance The optimal approach for treatment deescalation in human papillomavirus (HPV)–related
oropharyngeal squamous cell carcinomas (OPSCCs) is unknown. Objective To …

[HTML][HTML] Spatial transcriptomics reveals distinct and conserved tumor core and edge architectures that predict survival and targeted therapy response

…, RK Arora, TW Matthews, S Chandarana… - Nature …, 2023 - nature.com
The spatial organization of the tumor microenvironment has a profound impact on biology
and therapy response. Here, we perform an integrative single-cell and spatial transcriptomic …

[HTML][HTML] Treatment de-escalation for HPV-associated oropharyngeal squamous cell carcinoma with radiotherapy vs. trans-oral surgery (ORATOR2): study protocol for …

…, S Johnson-Obaseki, L Eapen, M Odell, S Chandarana… - BMC cancer, 2020 - Springer
Background Patients with human papillomavirus-positive (HPV+) oropharyngeal squamous
cell carcinoma (OPC) have substantially better treatment response and overall survival (OS) …

Molecular profiling of thyroid nodule fine-needle aspiration cytology

…, S Ghaznavi, C Symonds, SP Chandarana… - Nature Reviews …, 2017 - nature.com
The differential diagnosis and malignancy risk stratification of thyroid nodules requires
multidisciplinary expertise and knowledge of both local ultrasonography practices and the local …

Oncologic significance of therapeutic delays in patients with oral cavity cancer

…, A Eskander, X Hong, S Chandarana… - … –Head & Neck …, 2023 - jamanetwork.com
Importance Oral cavity cancer often requires multidisciplinary management, subjecting
patients to complex therapeutic trajectories. Prolonged treatment intervals in oral cavity cancer …

[HTML][HTML] NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma

…, SC Nakoneshny, TW Matthews, S Chandarana… - Cancer Gene …, 2023 - nature.com
There are few prognostic biomarkers and targeted therapeutics currently in use for the clinical
management of oral squamous cell carcinoma (OSCC) and patient outcomes remain poor …

Cost-effectiveness analysis of a postoperative clinical care pathway in head and neck surgery with microvascular reconstruction

…, M Hoy, A Lui, SP Chandarana… - … -head & neck …, 2013 - journals.sagepub.com
Background The objective of this study is to evaluate the cost-effectiveness of a postoperative
clinical care pathway for patients undergoing major head and neck oncologic surgery with …

[HTML][HTML] Efficacy of multimodal analgesia for postoperative pain management in head and neck cancer patients

A Hinther, SC Nakoneshny, SP Chandarana… - Cancers, 2021 - mdpi.com
Simple Summary Chronic opioid use is a serious global health problem and surgery is often
the point of initial exposure for many chronic opioid users. Multimodal analgesia (MMA) is …

Efficacy of postoperative pain management in head and neck cancer patients

…, SC Nakoneshny, SP Chandarana… - … -Head & Neck …, 2018 - journals.sagepub.com
Background Our study quantifies the effectiveness of perioperative pain control in a cohort
of patients undergoing major head and neck surgery with free flap reconstruction. Our long-…

[HTML][HTML] A qualitative study of patient and healthcare provider perspectives on building multiphasic exercise prehabilitation into the surgical care pathway for head and …

…, T Crump, GJ Francis, TW Matthews, SP Chandarana… - Current …, 2022 - mdpi.com
Head and neck cancer (HNC) surgical patients experience a high symptom burden. Multiphasic
exercise prehabilitation has the potential to improve patient outcomes, and to implement …